US FDA Finds ‘Significant’ Data Integrity Breaches In CRO Raptim Studies

 
• By Urtė Fultinavičiūtė
  
Hands holding a question mark and lightbulb
The FDA found data integrity issues in BE studies at Raptim Research conducted between 2019 and 2023. (Shutterstock)

More from Generics

More from Compliance